Jemma Hopewell

Professor Jemma Hopewell leads a team of genetic epidemiologists, clinical fellows, medical statisticians and bioinformaticians in a programme of research focusing on the use of genetic and clinical trial-based studies to investigate the causes and treatments for cardiovascular disease and arrhythmias. She has particular interests in using epidemiological, genetic and other large-scale 'omic approaches to improve understanding of drug targets and disease mechanisms, perform genomic characterisation of vascular disease and its risk factors, particularly Lp(a), and determine predictors of patient response to therapy. She leads and collaborates on numerous trial-based, epidemiological, and genetic epidemiological projects involving the Clinical Trials Service Unit and Epidemiological Studies Unit (CTSU)'s vascular mega-trials (such as HPS, SEARCH, THRIVE, REVEAL), large-scale studies and biobanks (such as PROCARDIS, UK Biobank), and international consortia (such as CARDIoGRAMplusC4D), wor